These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1363719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
    De Conca V, Saccomanno S, Dodero M, Aste H.
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
    [Abstract] [Full Text] [Related]

  • 3. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 4. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S, Liao CH.
    Am J Gastroenterol; 1990 Aug 11; 85(8):949-52. PubMed ID: 1973870
    [Abstract] [Full Text] [Related]

  • 5. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K, Chhina RS, Ghosh A, Kaura R.
    Trop Gastroenterol; 1999 Aug 11; 20(2):90-2. PubMed ID: 10484900
    [Abstract] [Full Text] [Related]

  • 6. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E.
    Z Gastroenterol; 1985 Dec 11; 23(12):665-9. PubMed ID: 2868581
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2].
    Tincani GP, Maniscalco G, Gunelli M, Ciarrocchi V.
    Minerva Med; 1987 Jun 30; 78(12):847-53. PubMed ID: 2885786
    [Abstract] [Full Text] [Related]

  • 8. Prevention of NSAID-gastropathy.
    Ardizzone S, Bianchi Porro G.
    Ital J Gastroenterol; 1996 Dec 30; 28 Suppl 4():33-6. PubMed ID: 9032581
    [Abstract] [Full Text] [Related]

  • 9. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Kodama M, Fujioka T.
    J Gastroenterol Hepatol; 2006 Jun 30; 21(6):1048-53. PubMed ID: 16724993
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH, Buttigieg RJ, Iseli A.
    Med J Aust; 1994 Feb 21; 160(4):192-6. PubMed ID: 7906009
    [Abstract] [Full Text] [Related]

  • 12. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
    Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL.
    J Int Med Res; 1989 Feb 21; 17 Suppl 1():25A-31A. PubMed ID: 2566541
    [Abstract] [Full Text] [Related]

  • 13. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 14. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P, Wong EC.
    J Gastroenterol Hepatol; 1989 Sep 22; 4 Suppl 2():75-81. PubMed ID: 2577478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer].
    Di Mario F, Gottardello L, Burra P, Salvagnini M, Dalrì L, Leandro G, Contento F, Torri A, Naccarato R.
    G Clin Med; 1990 Apr 22; 71(4):259-62, 265-6. PubMed ID: 1973392
    [Abstract] [Full Text] [Related]

  • 18. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK, Pal LS.
    J Indian Med Assoc; 1998 Apr 22; 96(4):106-8. PubMed ID: 9844330
    [Abstract] [Full Text] [Related]

  • 19. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG, Hansky J, Eaves ER, Schmidt GT.
    Gastroenterology; 1983 Oct 22; 85(4):871-4. PubMed ID: 6136450
    [Abstract] [Full Text] [Related]

  • 20. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S.
    Scand J Gastroenterol; 1993 Oct 22; 28(10):875-8. PubMed ID: 8266016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.